For research use only. Not for use in humans.

Cova322 (Anti-IL-17 & TNF-Alpha)

Cova322 is a bispecific FynomAb targeting TNF and IL-17A, created by fusing a small anti-IL-17A Fynomer to the anti-TNF antibody adalimumab. It shows potent inhibition of TNF and IL-17A in vitro and in vivo, offering potential benefits for inflammatory disease treatment. M.W 161.9 kDa.

Cova322 (Anti-IL-17 & TNF-Alpha)

Quality Control

Specificity

Name Citation TNF-α TNF-alpha Others
QNZ (EVP4593) 155 NF-κB
JTE-607 Dihydrochloride 0 IL-1beta,IL-8,IL-6
PF-3644022 1 MK2
UCB-9260 0 NF-κB
MD2-TLR4-IN-1 0 TLR4,IL-6
R-7050 8 IL-1β
Resatorvid (TAK-242) 62 TLR4,IL-6,NO
Apigenin-7-O-glucuronide 0
UTL-5g 0
Benpyrine racemate 1
Amarogentin 0 TAS2R1,AMPK
Stylopine 0 IL-1β,NO,COX-2
Myrislignan 1 iNOS,IL-6,NF-κB
NE 52-QQ57 1 iNOS,IL-6,IL-1β
(3R,8S)-Falcarindiol 3 IL-1β,IL-6,iNOS
Gardenoside 0 NF-κB,P2X7 Receptor,IL-6
Cucurbitacin IIb 0 JNK,STAT3,NF-κB
IQ 3 1 IL-6,JNK3,JNK1
Isuzinaxib (APX-115 free base) 0 IL-6,MCP-1/CCL2,NOX2
AUDA 0 Smad3,TGF-β,IL-1β
CPI-1189 1
Madecassic acid 1 IL-1β,COX-2,iNOS
Homoplantaginin 1 IL-6,IKKβ,NF-κB
2',5'-Dihydroxyacetophenone 1 IL-6,NF-κB,ERK1/2
Forsythoside B 0 IκB,NF-κB,IL-6
Mulberroside A 0 ERK,NF-κB,Caspase-1
Ginsenoside Rb1 4 TLR3,NF-κB,IRAK-1
Muscone 4 IL-6,IL-1β,NLRP3 inflammasome
(±)-Shikonin 38 NF-κB,Proteasome,chemokine receptor
Methylthiouracil 0 IL-6,ERK1/2,NF-κB
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Cova322 is a bispecific FynomAb targeting TNF and IL-17A, created by fusing a small anti-IL-17A Fynomer to the anti-TNF antibody adalimumab. It shows potent inhibition of TNF and IL-17A in vitro and in vivo, offering potential benefits for inflammatory disease treatment. M.W 161.9 kDa.

Product Details

CAS No. N/A
Source CHO
Storage
(From the date of receipt)
-80℃(avoid freeze-thaw cycles)

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.